<i>Map2k4</i> Functions as a Tumor Suppressor in Lung Adenocarcinoma and Inhibits Tumor Cell Invasion by Decreasing Peroxisome Proliferator-Activated Receptor γ2 Expression
Young‐Ho Ahn(Ewha Womans University), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Nishan Thilaganathan(The University of Texas MD Anderson Cancer Center), Jonathon D. Roybal(The University of Texas MD Anderson Cancer Center), Chad J. Creighton(Baylor College of Medicine), Fei Yang(Roche (Switzerland)), Elizabeth J. Goldsmith(The University of Texas Southwestern Medical Center), Cathy Tournier(University of Manchester), Yanan Yang(Shanghai Medical College of Fudan University), Cristina A. Alvarez(The University of Texas MD Anderson Cancer Center), Wei Lin(Fujian University of Traditional Chinese Medicine), Don L. Gibbons(The University of Texas MD Anderson Cancer Center)
Cited by 70
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k